Review
doi: 10.1016/j.ahj.2007.12.034.
Antiplatelet drug nonresponsiveness
Affiliations
- PMID: 18371464
- DOI: 10.1016/j.ahj.2007.12.034
Item in Clipboard
Review
Antiplatelet drug nonresponsiveness
Am Heart J.
2008 Apr.
Erratum in
- Am Heart J. 2008 Sep;156(3):563
Abstract
The response to most medication, including antiplatelet drugs, is highly variable between individuals. Observational studies have shown that nonresponders to antiplatelet agents appear to have an increased incidence of vascular events. This review article reviews the background, mechanisms, and evidence in support of the clinical significance of this phenomenon.
Similar articles
-
Platelet function monitoring in patients with coronary artery disease.J Am Coll Cardiol. 2007 Nov 6;50(19):1822-34. doi: 10.1016/j.jacc.2007.07.051. Epub 2007 Oct 23. J Am Coll Cardiol. 2007. PMID: 17980247 Review.
-
Current antiplatelet therapies: benefits and limitations.Am Heart J. 2008 Aug;156(2 Suppl):S3-9. doi: 10.1016/j.ahj.2008.06.003. Am Heart J. 2008. PMID: 18657680 Review.
-
Antiplatelet agents used for early intervention in acute coronary syndrome: myocardial salvage versus bleeding complications.J Thorac Cardiovasc Surg. 2009 Oct;138(4):807-10. doi: 10.1016/j.jtcvs.2009.04.052. J Thorac Cardiovasc Surg. 2009. PMID: 19769880 No abstract available.
-
Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy.Am J Cardiol. 2009 Jul 15;104(2):227-33. doi: 10.1016/j.amjcard.2009.03.022. Epub 2009 May 13. Am J Cardiol. 2009. PMID: 19576352 Review.
-
Dual antiplatelet therapy in ACS: time-dependent variability in platelet aggregation during the first week.Indian Heart J. 2009 Mar-Apr;61(2):173-7. Indian Heart J. 2009. PMID: 20039503
Cited by
-
Cytochrome P450 2C19 polymorphism is associated with poor clinical outcomes in coronary artery disease patients treated with clopidogrel.Mol Biol Rep. 2011 Mar;38(3):1697-702. doi: 10.1007/s11033-010-0282-0. Epub 2010 Sep 16. Mol Biol Rep. 2011. PMID: 20845077
-
P2Y12 Receptor Inhibitors in Acute Coronary Syndromes: What Is New on the Horizon?Cardiol Res Pract. 2013;2013:195456. doi: 10.1155/2013/195456. Epub 2013 Feb 19. Cardiol Res Pract. 2013. PMID: 23533940 Free PMC article.
-
Acute coronary syndromes: advances in antithrombotics.Curr Atheroscler Rep. 2013 Apr;15(4):318. doi: 10.1007/s11883-013-0318-8. Curr Atheroscler Rep. 2013. PMID: 23456409 Review.
-
Antithrombotic therapy for the CardioWest temporary total artificial heart.Tex Heart Inst J. 2010;37(2):149-58. Tex Heart Inst J. 2010. PMID: 20401285 Free PMC article. Review.
-
Panax quinquefolius saponins combined with dual antiplatelet drug therapy alleviate gastric mucosal injury and thrombogenesis through the COX/PG pathway in a rat model of acute myocardial infarction.PLoS One. 2018 Mar 27;13(3):e0194082. doi: 10.1371/journal.pone.0194082. eCollection 2018. PLoS One. 2018. PMID: 29584740 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
